Tyra Biosciences, Inc. (TYRA) Balance Sheet
As of 2026-06-30 (10-Q), Tyra Biosciences, Inc. (TYRA) reported total assets of $383.4M, total liabilities of $29.7M and shareholders' equity of $353.7M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $73.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TYRATyra Biosciences, Inc.Follow TYRA — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 302.2 | 251.2 | 58.0 | 92.0 | 77.4 | 73.8 | |
| Current assets | 304.1 | 257.3 | 211.7 | 347.5 | 265.5 | 367.0 | |
| Total assets | 306.7 | 266.2 | 225.9 | 363.6 | 282.6 | 383.4 | |
| Current liabilities | 3.6 | 5.7 | 15.3 | 14.6 | 18.1 | 24.6 | |
| Total liabilities | 5.0 | 8.4 | 21.6 | 20.4 | 23.4 | 29.7 | |
| Shareholders' equity | 301.7 | 257.8 | 204.3 | 343.2 | 259.2 | 353.7 |
USD millions · SEC XBRL
Tyra Biosciences, Inc. — questions
- How much cash does Tyra Biosciences, Inc. have?
- $73.8M in cash and cash equivalents as of 2026-06-30.
- What are Tyra Biosciences, Inc.'s total assets?
- $383.4M as of 2026-06-30.
- What is Tyra Biosciences, Inc.'s shareholders' equity?
- $353.7M as of 2026-06-30.
Every figure on this page comes from Tyra Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.